Targeting carcinogen metabolism by dietary cancer preventive compounds

Siwang Yu1, Ah-Ng Kong

  • 1Center for Cancer Prevention Research, Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.

Insights

Dietary compounds, particularly phytochemicals, can prevent cancer by modulating carcinogen metabolism. Key pathways like Nrf2/ARE and nuclear receptors are targeted, influencing enzyme and transporter activity for detoxification and excretion.

Area of Science:

  • Molecular Biology
  • Nutritional Science
  • Cancer Prevention

Background:

  • Cancer prevention is crucial, with dietary bioactive compounds showing promise.
  • Phytochemicals are key dietary compounds that can reduce cancer risk.
  • Modulating carcinogen metabolism is a primary mechanism for cancer prevention by diet.

Purpose of the Study:

  • To review molecular targets of dietary compounds in carcinogen metabolism.
  • To examine regulatory signaling pathways, enzymes, and transporters involved.
  • To understand how diet influences cancer risk at a molecular level.

Main Methods:

  • Review of scientific literature on carcinogen metabolism and dietary compounds.
  • Analysis of molecular targets including xenobiotic receptors and signaling pathways (e.g., AhR, CAR, PXR, RXR, Nrf2/ARE).
  • Examination of Phase I, II, and III enzymes and transporters involved in carcinogen disposition.

Main Results:

  • Dietary compounds target nuclear receptors (AhR, CAR, PXR, RXR) regulating Phase I enzymes.
  • The Nrf2/ARE pathway is a major target, controlling Phase II detoxifying enzymes.
  • Phase III transporters are coordinately regulated with metabolizing enzymes, influencing excretion.

Conclusions:

  • Dietary compounds influence carcinogen metabolism via multiple molecular targets and pathways.
  • Genetic polymorphisms impact individual responses to dietary cancer prevention strategies.
  • Understanding these complex networks is key to predicting clinical outcomes of dietary interventions.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...